PROTAGONIST THERAPEUTICS INC

Ticker: PTGX CUSIP: 74366E102 Class: Common Stock

Candriam S.C.A.'s Holding History (CIK: 0001537014)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 162,492 Value ($000) $7,312 Avg Close $40.40 Range $32.50 - $48.00
Q2 2024
Shares 273,818 Value ($000) $9,487 Avg Close $29.29 Range $24.22 - $35.96
Q1 2024
Shares 360,000 Value ($000) $10,415 Avg Close $27.21 Range $21.43 - $33.34
Q4 2023
Shares 537,000 Value ($000) $12,314 Avg Close $17.50 Range $13.72 - $23.88
Q3 2023
Shares 630,000 Value ($000) $10,508 Avg Close $19.40 Range $16.33 - $26.81
Q2 2023
Shares 725,000 Value ($000) $20,025 Avg Close $25.03 Range $17.64 - $30.10
Q1 2023
Shares 625,000 Value ($000) $13,231 Avg Close $16.79 Range $10.62 - $25.69
Q1 2022
Shares 83,646 Value ($000) $1,981 Avg Close $28.17 Range $22.56 - $37.05
Q4 2021
Shares 83,646 Value ($000) $2,861 Avg Close $31.61 Range $17.26 - $38.11
Q3 2021
Shares 83,646 Value ($000) $1,482 Avg Close $42.63 Range $12.80 - $50.54
Q2 2021
Shares 83,646 Value ($000) $3,754 Avg Close $33.01 Range $24.14 - $45.93